Johnson & Johnson

As of June 30, 2026, Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs carries a market capitalization of 574.28B, placing it among publicly traded companies globally. Its enterprise value stands at 602.55B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs's next confirmed earnings release is scheduled for January 26, 2027.

As of June 30, 2026, Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs has 33.80B shares outstanding.

As of June 30, 2026, Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs trades at a trailing price-to-earnings ratio of 27.29. The price-to-sales ratio is 5.86, and the price-to-book ratio stands at 6.76.

As of June 30, 2026, Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs trades at an EV/EBITDA multiple of 18.55 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 6.15 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 24.37 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs trades at an EV/FCF ratio of 26.12, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 602.55B versus a market cap of 574.28B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs maintains a current ratio of 1.09, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 57.71, indicating elevated leverage, while an interest coverage ratio of 32.09 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs posted a return on equity (ROE) of 25.74, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 15.55 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 10.67, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 16.63, useful for judging operating efficiency across full business cycles. The company generates approximately 696,755.60 in revenue per employee across its workforce of 140,550.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.20 indicates how many times Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs recorded 4.16B in income tax expense. That works out to an effective tax rate of 16.51, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 25.20B, leaving 21.04B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs's stock has gained approximately 37.38% over the past 52 weeks.

Over the twelve months ended June 30, 2026, Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs generated 97.93B in revenue and converted that into 21.04B in net income, yielding earnings per share of 0.61. EBITDA reached 32.48B, while operating income came in at 26.26B.

As of June 30, 2026, Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs holds 20.76B in cash and equivalents against 49.04B in total debt, resulting in a net debt position of 28.61B. Total book value stands at 84.97B, with working capital of 4.88B providing operational flexibility.

Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs produced 27.61B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -5.38B in capital expenditures, free cash flow totaled 22.23B - equivalent to 0.66 per share.

Over the twelve months ended June 30, 2026, Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs posted a gross margin of 67.91, reflecting its pricing power and cost economics. The operating margin of 26.81 and net profit margin of 21.48 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs paid dividends of 0.37 per share. The dividend payout ratio of 59.99 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 3.82, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 3.23, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs shareholders.

Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs's most recent stock split took place on November 17, 2022 with a 1:3 split ratio.